317 related articles for article (PubMed ID: 24827035)
1. A form of the metabolic syndrome associated with mutations in DYRK1B.
Keramati AR; Fathzadeh M; Go GW; Singh R; Choi M; Faramarzi S; Mane S; Kasaei M; Sarajzadeh-Fard K; Hwa J; Kidd KK; Babaee Bigi MA; Malekzadeh R; Hosseinian A; Babaei M; Lifton RP; Mani A
N Engl J Med; 2014 May; 370(20):1909-1919. PubMed ID: 24827035
[TBL] [Abstract][Full Text] [Related]
2. DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain.
Abu Jhaisha S; Widowati EW; Kii I; Sonamoto R; Knapp S; Papadopoulos C; Becker W
Sci Rep; 2017 Jul; 7(1):6420. PubMed ID: 28743892
[TBL] [Abstract][Full Text] [Related]
3. The metabolic syndrome and DYRK1B.
Morita H; Komuro I
N Engl J Med; 2014 Aug; 371(8):785. PubMed ID: 25140975
[No Abstract] [Full Text] [Related]
4. The metabolic syndrome and DYRK1B.
He JL; Qiao GF; Li BY
N Engl J Med; 2014 Aug; 371(8):785. PubMed ID: 25140974
[No Abstract] [Full Text] [Related]
5. The metabolic syndrome and DYRK1B.
Mirshahi T; Murray MF; Carey DJ
N Engl J Med; 2014 Aug; 371(8):784-5. PubMed ID: 25140973
[No Abstract] [Full Text] [Related]
6. The metabolic syndrome and DYRK1B.
Keramati AR; Fathzadeh M; Mani A
N Engl J Med; 2014 Aug; 371(8):785-6. PubMed ID: 25140972
[No Abstract] [Full Text] [Related]
7. DYRK1B variant linked to autosomal dominant metabolic syndrome.
Hickmott J
Clin Genet; 2015 Jan; 87(1):30-1. PubMed ID: 25092113
[No Abstract] [Full Text] [Related]
8. Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome.
Ashford AL; Dunkley TP; Cockerill M; Rowlinson RA; Baak LM; Gallo R; Balmanno K; Goodwin LM; Ward RA; Lochhead PA; Guichard S; Hudson K; Cook SJ
Cell Mol Life Sci; 2016 Feb; 73(4):883-900. PubMed ID: 26346493
[TBL] [Abstract][Full Text] [Related]
9. Genetics: Founder mutations identified in an inherited form of the metabolic syndrome.
Holmes D
Nat Rev Endocrinol; 2014 Jul; 10(7):377. PubMed ID: 24889900
[No Abstract] [Full Text] [Related]
10. DYRK1B haploinsufficiency in a family with metabolic syndrome and abnormal cognition.
Orenstein N; Gofin Y; Shomron N; Ruhrman-Shahar N; Magal N; Hagari O; Azulay N; Bazak L; Goldberg Y; Basel-Salmon L
Clin Genet; 2022 Feb; 101(2):265-266. PubMed ID: 34786696
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing variants of dual specificity tyrosine phosphorylated and regulated kinase 1B exhibit distinct patterns of expression and functional properties.
Leder S; Czajkowska H; Maenz B; De Graaf K; Barthel A; Joost HG; Becker W
Biochem J; 2003 Jun; 372(Pt 3):881-8. PubMed ID: 12633499
[TBL] [Abstract][Full Text] [Related]
12. Study of DYRK1B gene expression and its association with metabolic syndrome in a small cohort of Egyptians.
Mohamed YA; Hassaneen HM; El-Dessouky MA; Safwat G; Hassan NA; Amr K
Mol Biol Rep; 2021 Jul; 48(7):5497-5502. PubMed ID: 34291393
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A.
Widowati EW; Bamberg-Lemper S; Becker W
BMC Res Notes; 2018 May; 11(1):297. PubMed ID: 29764512
[TBL] [Abstract][Full Text] [Related]
14. Dyrk1b promotes autophagy during skeletal muscle differentiation by upregulating 4e-bp1.
Bhat N; Narayanan A; Fathzadeh M; Shah K; Dianatpour M; Abou Ziki MD; Mani A
Cell Signal; 2022 Feb; 90():110186. PubMed ID: 34752933
[TBL] [Abstract][Full Text] [Related]
15. High diagnostic yield of clinically unidentifiable syndromic growth disorders by targeted exome sequencing.
Kim YM; Lee YJ; Park JH; Lee HD; Cheon CK; Kim SY; Hwang JY; Jang JH; Yoo HW
Clin Genet; 2017 Dec; 92(6):594-605. PubMed ID: 28425089
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis.
Masaki S; Kii I; Sumida Y; Kato-Sumida T; Ogawa Y; Ito N; Nakamura M; Sonamoto R; Kataoka N; Hosoya T; Hagiwara M
Bioorg Med Chem; 2015 Aug; 23(15):4434-4441. PubMed ID: 26145823
[TBL] [Abstract][Full Text] [Related]
17. Protein quality control of DYRK family protein kinases by the Hsp90-Cdc37 molecular chaperone.
Miyata Y; Nishida E
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119081. PubMed ID: 34147560
[TBL] [Abstract][Full Text] [Related]
18. LRP6 mutation in a family with early coronary disease and metabolic risk factors.
Mani A; Radhakrishnan J; Wang H; Mani A; Mani MA; Nelson-Williams C; Carew KS; Mane S; Najmabadi H; Wu D; Lifton RP
Science; 2007 Mar; 315(5816):1278-82. PubMed ID: 17332414
[TBL] [Abstract][Full Text] [Related]
19. Analysis of DYRK1B, PPARG, and CEBPB Expression Patterns in Adipose-Derived Stem Cells from Patients Carrying DYRK1B R102C and Healthy Individuals During Adipogenesis.
Armanmehr A; Jafari Khamirani H; Zoghi S; Dianatpour M
Metab Syndr Relat Disord; 2022 Dec; 20(10):576-583. PubMed ID: 36318489
[No Abstract] [Full Text] [Related]
20. Two novel variants in DYRK1B causative of AOMS3: expanding the clinical spectrum.
Mendoza-Caamal EC; Barajas-Olmos F; Mirzaeicheshmeh E; Ilizaliturri-Flores I; Aguilar-Salinas CA; Gómez-Velasco DV; Cicerón-Arellano I; Reséndiz-Rodríguez A; Martínez-Hernández A; Contreras-Cubas C; Islas-Andrade S; Zerrweck C; García-Ortiz H; Orozco L
Orphanet J Rare Dis; 2021 Jun; 16(1):291. PubMed ID: 34193236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]